ARCHIVES

Medicare to cut payments for cancer drugs by 2-8%. ASCO estimates total cut in reimbursement at $500 million.

This article is from The Cancer Letter archive.

Vol. 30 No. 31 | July 30, 2004

Download PDF Visit The Full Archive

Related Articles

UC Davis Study Finds Patients Need Practical Information

June 28, 2002

In Brief

February 7, 2014

The First BRCA1 Test Hits The Market; Are Oncologists, Patients Ready?

January 26, 1996

FDA Promises No More IND Disruptions Without “Very Valid Reasons,” Nears Agreement With NCI

April 15, 1977

Proposed Criteria For Establishing Carcinogenicity Listed

November 21, 1975

In Brief: Bristol Dedicates New Research center; MSK Presents Awards to Sen. Moyniham, 10 Others

July 11, 1986